{
    "code": "52027254",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027254",
    "time": "2022-10-14 05:11:25",
    "許可證字號": "衛部藥輸字第027254號",
    "註銷狀態": "已註銷",
    "註銷日期": "108\/03\/22",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "111\/09\/06",
    "發證日期": "106\/09\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202725402",
    "中文品名": "&quot;愛爾康新加坡廠&quot;威爾眸點眼液0.5%",
    "英文品名": "VIGAMOX Sterile Ophthalmic Solution 0.5% (Singapore)",
    "適應症": "治療下列微生物具感受性的菌株所引起的細菌性結膜炎。好氧性革蘭氏陽性菌：Corynebacterium species1、Micrococcus luteus1、Staphylococcus aureus、Staphylococcus epidermidis、Staphylococcus haemolyticus、Staphylococcus hominis、Staphylococcus warneri1、Streptococcus pneumoniae、Streptococcus viridans group好氧性革蘭氏陰性菌：Acinetobacter Iwoffii1、Haemophilus influenzae、Haemophilus parainfluenzae1其他：Chlamydia trachomatis（1對此細菌有效性的研究少於10個感染數）。",
    "劑型": "46A無菌眼用液劑",
    "包裝": "100毫升以下LDPE塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MOXIFLOXACIN HYDROCHLORIDE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": [
        {
            "製造廠名稱": "FSG0040000  Alcon Singapore Manufacturing Pte. Ltd.",
            "製造廠廠址": "19 Tuas South Avenue 14, Singapore 637313",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700910",
            "成分名稱": "MOXIFLOXACIN HYDROCHLORIDE",
            "含量描述": "(eq. to Moxifloxacin.....5mg) (Potency)",
            "含量": "5.4500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "藥物外觀-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027254&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "06_ATL.v2_Vigamox.cht_ASM_201608-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027254&Seq=001&Type=9"
        },
        {
            "title": "1.6.2_Label-A137040_L_VIG_5mL_SG-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027254&Seq=003&Type=8"
        },
        {
            "title": "1.6.2_Label.ch_Vigamox ASM_201801-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027254&Seq=002&Type=8"
        },
        {
            "title": "1.6.2_Box-A137039_C_VIG_5mL-107-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027254&Seq=001&Type=8"
        }
    ]
}